Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation

Andrew Xiao, Chaoying Yin, Chunyu Yang, Antonio Di Cristofano, Pier Paolo Pandolfi, Terry Van Dyke

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

High-grade astrocytomas are invariably deadly and minimally responsive to therapy. Pten is frequently mutated in aggressive astrocytoma but not in low-grade astrocytoma. However, the Pten astrocytoma suppression mechanisms are unknown. Here we introduced conditional null alleles of Pten (Pten loxp/loxp) into a genetically engineered mouse astrocytoma model [TgG(ΔZ)T121] in which the pRb family proteins are inactivated specifically in astrocytes. Pten inactivation was induced by localized somatic retroviral (MSCV)-Cre delivery. Depletion of Pten function in adult astrocytoma cells alleviated the apoptosis evoked by pRb family protein inactivation and also induced tumor cell invasion. In primary astrocytes derived from TgG(ΔZ)T121; Ptenloxp/loxp mice, Pten deficiency resulted in a marked increase in cell invasiveness that was suppressed by inhibitors of protein kinase C (PKC) or of PKC-ζ, specifically. Finally, focal induction of Pten deficiency in vivo promoted angiogenesis in affected brains. Thus, we show that Pten deficiency in pRb-deficient astrocytoma cells contributes to tumor progression via multiple mechanisms, including suppression of apoptosis, increased cell invasion, and angiogenesis, all of which are hallmarks of high-grade astrocytoma. These studies not only provide mechanistic insight into the role of Pten in astrocytoma suppression but also describe a valuable animal model for preclinical testing that is coupled with a primary cell-based system for target discovery and drug screening.

Original languageEnglish (US)
Pages (from-to)5172-5180
Number of pages9
JournalCancer Research
Volume65
Issue number12
DOIs
StatePublished - Jun 15 2005
Externally publishedYes

Fingerprint

Astrocytoma
Disease Progression
Astrocytes
Protein Kinase C
Apoptosis
Preclinical Drug Evaluations
Neoplasms
Proteins
Animal Models
Alleles
Brain

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation. / Xiao, Andrew; Yin, Chaoying; Yang, Chunyu; Di Cristofano, Antonio; Pandolfi, Pier Paolo; Van Dyke, Terry.

In: Cancer Research, Vol. 65, No. 12, 15.06.2005, p. 5172-5180.

Research output: Contribution to journalArticle

Xiao, Andrew ; Yin, Chaoying ; Yang, Chunyu ; Di Cristofano, Antonio ; Pandolfi, Pier Paolo ; Van Dyke, Terry. / Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation. In: Cancer Research. 2005 ; Vol. 65, No. 12. pp. 5172-5180.
@article{11aff43842804b2097c8f064e5dd71ee,
title = "Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation",
abstract = "High-grade astrocytomas are invariably deadly and minimally responsive to therapy. Pten is frequently mutated in aggressive astrocytoma but not in low-grade astrocytoma. However, the Pten astrocytoma suppression mechanisms are unknown. Here we introduced conditional null alleles of Pten (Pten loxp/loxp) into a genetically engineered mouse astrocytoma model [TgG(ΔZ)T121] in which the pRb family proteins are inactivated specifically in astrocytes. Pten inactivation was induced by localized somatic retroviral (MSCV)-Cre delivery. Depletion of Pten function in adult astrocytoma cells alleviated the apoptosis evoked by pRb family protein inactivation and also induced tumor cell invasion. In primary astrocytes derived from TgG(ΔZ)T121; Ptenloxp/loxp mice, Pten deficiency resulted in a marked increase in cell invasiveness that was suppressed by inhibitors of protein kinase C (PKC) or of PKC-ζ, specifically. Finally, focal induction of Pten deficiency in vivo promoted angiogenesis in affected brains. Thus, we show that Pten deficiency in pRb-deficient astrocytoma cells contributes to tumor progression via multiple mechanisms, including suppression of apoptosis, increased cell invasion, and angiogenesis, all of which are hallmarks of high-grade astrocytoma. These studies not only provide mechanistic insight into the role of Pten in astrocytoma suppression but also describe a valuable animal model for preclinical testing that is coupled with a primary cell-based system for target discovery and drug screening.",
author = "Andrew Xiao and Chaoying Yin and Chunyu Yang and {Di Cristofano}, Antonio and Pandolfi, {Pier Paolo} and {Van Dyke}, Terry",
year = "2005",
month = "6",
day = "15",
doi = "10.1158/0008-5472.CAN-04-3902",
language = "English (US)",
volume = "65",
pages = "5172--5180",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "12",

}

TY - JOUR

T1 - Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation

AU - Xiao, Andrew

AU - Yin, Chaoying

AU - Yang, Chunyu

AU - Di Cristofano, Antonio

AU - Pandolfi, Pier Paolo

AU - Van Dyke, Terry

PY - 2005/6/15

Y1 - 2005/6/15

N2 - High-grade astrocytomas are invariably deadly and minimally responsive to therapy. Pten is frequently mutated in aggressive astrocytoma but not in low-grade astrocytoma. However, the Pten astrocytoma suppression mechanisms are unknown. Here we introduced conditional null alleles of Pten (Pten loxp/loxp) into a genetically engineered mouse astrocytoma model [TgG(ΔZ)T121] in which the pRb family proteins are inactivated specifically in astrocytes. Pten inactivation was induced by localized somatic retroviral (MSCV)-Cre delivery. Depletion of Pten function in adult astrocytoma cells alleviated the apoptosis evoked by pRb family protein inactivation and also induced tumor cell invasion. In primary astrocytes derived from TgG(ΔZ)T121; Ptenloxp/loxp mice, Pten deficiency resulted in a marked increase in cell invasiveness that was suppressed by inhibitors of protein kinase C (PKC) or of PKC-ζ, specifically. Finally, focal induction of Pten deficiency in vivo promoted angiogenesis in affected brains. Thus, we show that Pten deficiency in pRb-deficient astrocytoma cells contributes to tumor progression via multiple mechanisms, including suppression of apoptosis, increased cell invasion, and angiogenesis, all of which are hallmarks of high-grade astrocytoma. These studies not only provide mechanistic insight into the role of Pten in astrocytoma suppression but also describe a valuable animal model for preclinical testing that is coupled with a primary cell-based system for target discovery and drug screening.

AB - High-grade astrocytomas are invariably deadly and minimally responsive to therapy. Pten is frequently mutated in aggressive astrocytoma but not in low-grade astrocytoma. However, the Pten astrocytoma suppression mechanisms are unknown. Here we introduced conditional null alleles of Pten (Pten loxp/loxp) into a genetically engineered mouse astrocytoma model [TgG(ΔZ)T121] in which the pRb family proteins are inactivated specifically in astrocytes. Pten inactivation was induced by localized somatic retroviral (MSCV)-Cre delivery. Depletion of Pten function in adult astrocytoma cells alleviated the apoptosis evoked by pRb family protein inactivation and also induced tumor cell invasion. In primary astrocytes derived from TgG(ΔZ)T121; Ptenloxp/loxp mice, Pten deficiency resulted in a marked increase in cell invasiveness that was suppressed by inhibitors of protein kinase C (PKC) or of PKC-ζ, specifically. Finally, focal induction of Pten deficiency in vivo promoted angiogenesis in affected brains. Thus, we show that Pten deficiency in pRb-deficient astrocytoma cells contributes to tumor progression via multiple mechanisms, including suppression of apoptosis, increased cell invasion, and angiogenesis, all of which are hallmarks of high-grade astrocytoma. These studies not only provide mechanistic insight into the role of Pten in astrocytoma suppression but also describe a valuable animal model for preclinical testing that is coupled with a primary cell-based system for target discovery and drug screening.

UR - http://www.scopus.com/inward/record.url?scp=20444484560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20444484560&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-04-3902

DO - 10.1158/0008-5472.CAN-04-3902

M3 - Article

C2 - 15958561

AN - SCOPUS:20444484560

VL - 65

SP - 5172

EP - 5180

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 12

ER -